A case of arthritis and vasculitis associated with the refractory anemia with excess of blasts syndrome resistant to glucocorticoid treatment that responded favorably to TNF-alpha blockade.
Pipitone
N
N
Rheumatology Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
Masini
L
L
Salvarani
C
C
D000368:Aged; D000754:Anemia, Refractory, with Excess of Blasts / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D004351:Drug Resistance; D000068800:Etanercept; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009363:Neoplasm Proteins / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000627:therapeutic use*; D053319:Tumor Necrosis Factor Decoy Receptors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014657:Vasculitis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology
D000911:Antibodies, Monoclonal; D005938:Glucocorticoids; D007074:Immunoglobulin G; D009363:Neoplasm Proteins; D018124:Receptors, Tumor Necrosis Factor; D047889:Receptors, Tumor Necrosis Factor, Type II; D053319:Tumor Necrosis Factor Decoy Receptors; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept; D008775:Methylprednisolone